Dianna Shafer talks about how bone health goes with prostate health treatment, and trying to avoid skeletal health events. Read More ›

Dianna Shafer and Angela Hunter talk about the DEXA scan results, and how the implementation of a specific therapy helped decrease bone-related issues. Read More ›

Pam Skurkay talks about when providers consider prescribing one class of drugs versus another with factors that include the patient's insurance and overall health. Read More ›

Pam Skurkay talks about when she and other nurses began using a medicine to treat bone-related health issues and how they eventually allowed outside medical offices the pre-authorization to use it. Read More ›

Pam Skurkay, Dianna Shafer, and Angela Hunter discuss the positive scan results they are seeing post-immunotherapy when using denosumab. Read More ›

Pam Skurkay talks about why taking an injectable is seen as beneficial for patient preferences. Read More ›

Dianna Shafer talks about the testing protocol when examining patients’ bones and what they prescribe to ensure their patients’ bone health is being addressed. Read More ›

Pam Skurkay discusses the comparison rate of skeletal related events in bisphosphonates versus Xgeva. Read More ›

Pam Skurkay, Dianna Shafer, and Angela Hunter talk about following patients taking bisphosphonates and those who take Xgeva. Read More ›

Pam Skurkay, Dianna Shafer, and Angela Hunter discuss the rates of incidences of this issue as well as the benefits of using Xgeva, including a better quality of life for patients. Read More ›